Current Ratio of Avalo Therapeutics, Inc. from 30 Jun 2016 to 30 Sep 2025

Taxonomy & unit
ratio: %
Description
The current ratio is a liquidity ratio that measures a company's ability to cover its short-term obligations with its current assets.
Summary
Avalo Therapeutics, Inc. quarterly Current Ratio in % history and change rate from 30 Jun 2016 to 30 Sep 2025.
  • Avalo Therapeutics, Inc. Current Ratio for the quarter ending 30 Sep 2025 was 1660%, a 1977% increase year-over-year.
Current Ratio, Quarterly (%)
Current Ratio, YoY Quarterly Change (%)

Avalo Therapeutics, Inc. Quarterly Current Ratio (%)

Period Value YoY Chg Change % Date
Q3 2025 1660% +1580% +1977% 30 Sep 2025
Q2 2025 566% +496% +701% 30 Jun 2025
Q1 2025 264% +208% +370% 31 Mar 2025
Q4 2024 114% +29% +34% 31 Dec 2024
Q3 2024 80% +4.3% +5.7% 30 Sep 2024
Q2 2024 71% -2.2% -3% 30 Jun 2024
Q1 2024 56% -33% -37% 31 Mar 2024
Q4 2023 85% -44% -34% 31 Dec 2023
Q3 2023 76% -121% -61% 30 Sep 2023
Q2 2023 73% -201% -73% 30 Jun 2023
Q1 2023 89% -204% -70% 31 Mar 2023
Q4 2022 129% -139% -52% 31 Dec 2022
Q3 2022 196% -42% -18% 30 Sep 2022
Q2 2022 274% +72% +36% 30 Jun 2022
Q1 2022 293% +68% +30% 31 Mar 2022
Q4 2021 267% +36% +15% 31 Dec 2021
Q3 2021 239% +9.5% +4.1% 30 Sep 2021
Q2 2021 201% +22% +13% 30 Jun 2021
Q1 2021 225% +115% +105% 31 Mar 2021
Q4 2020 231% +138% +149% 31 Dec 2020
Q3 2020 229% +146% +176% 30 Sep 2020
Q2 2020 179% +96% +116% 30 Jun 2020
Q1 2020 110% +29% +37% 31 Mar 2020
Q4 2019 93% +16% +20% 31 Dec 2019
Q3 2019 83% +5.3% +6.8% 30 Sep 2019
Q2 2019 83% -46% -36% 30 Jun 2019
Q1 2019 80% -99% -55% 31 Mar 2019
Q4 2018 77% -160% -67% 31 Dec 2018
Q3 2018 78% -241% -76% 30 Sep 2018
Q2 2018 129% -23% -15% 30 Jun 2018
Q1 2018 180% +29% +20% 31 Mar 2018
Q4 2017 237% +53% +29% 31 Dec 2017
Q3 2017 319% +85% +36% 30 Sep 2017
Q2 2017 152% -66% -30% 30 Jun 2017
Q1 2017 150% 31 Mar 2017
Q4 2016 184% 31 Dec 2016
Q3 2016 234% 30 Sep 2016
Q2 2016 218% 30 Jun 2016
* An asterisk sign (*) next to the value indicates that the value is likely invalid.